Physician profile
Andrea Michele Hill
NPI 1710419858
$1,300.21
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.65 · 2022: $127 · 2023: $323 · 2024: $751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,074.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,073.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $616.71 | 2021-2024 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $165.39 | 2022-2024 | Jornay Pm |
| Corium, LLC | $150.97 | 2022-2024 | Azstarys |
| Sanofi Pasteur INC. | $62.69 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $62.68 | 2021-2022 | |
| Cranial Technologies, INC | $58.19 | 2023-2024 | Doc Band |
| Tris Pharma INC | $32.05 | 2024 | Dyanavel Xr |
| Pfizer INC. | $28.70 | 2023 | |
| Mayne Pharma Commercial LLC | $27.96 | 2024 | |
| Coopersurgical, INC. | $19.34 | 2024 | Paragard T 380a |
| Kyowa Kirin, INC. | $18.48 | 2022 | |
| Glaxosmithkline, LLC. | $16.57 | 2024 | Bexsero |
| Shield Therapeutics INC | $15.07 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.25 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $12.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.